Clinical Trials in the USA / NCT07782229
Recruiting
Not applicable
Appetite and Cognition Response to a Breakfast Cereal
NCT07782229 · tracked via the Priya Life Science USA tracker
Condition(s) studied
Cognition
Investigational drug(s) / intervention(s)
Ready-To-Eat Cereal
Ready-To-Eat Cereal: Packaged Ready-To-Eat Cereal product available in retail stores
Study summary
The purpose of this study is to examine appetite and cognition responses following consumption of a ready-to-eat breakfast cereal.
Eligibility
Inclusion Criteria:
* Healthy adults 18-70 years
* Habitual breakfast cereal consumers (at least several times per month)
* Body mass index 18.5-29.9 kg/m2 (based on self-reported weight and height)
* Understand and willing to follow the study procedures, including having access to a tablet or laptop to use the online platforms for appetite and cognition measurement
* Willing to maintain habitual diet, physical activity pattern, and body weight throughout the trial
* Willing to abstain from strenuous exercise, consuming alcoholic drinks 24 hours before the test day
* Willing to provide informed consent to participate in the study
Exclusion Criteria:
* Age or body mass index outside of the inclusion criteria
* Pregnant or lactating women, or women who are planning to become pregnant during the study
* Known food allergies, sensitivities, or intolerance to any food or food ingredients
* Participating in another clinical trial for food, investigational drug, nutritional supplement, or lifestyle modification
* Taking medications that affect appetite, metabolism or blood pressure
* Presence of acute diseases or infection
* Presence or history of chronic diseases
* Diagnosed with an eating disorder
* Restraint eaters as determined by a score \>4 from the Dutch Eating Behavior Questionnaire1
* Lost or gained 5 or more pounds in the past 3-months
* On a weight loss diet or undergoing intermittent fasting
* COVID-19 infection within the past 3 months
* Subjects who do not eat cereal products
* Subjects who do not understand or are not willing to follow the study procedures
Primary outcome measure(s)
- Rapid Visual Information Processing Task — 210 minutes
This computer-based task requires participants to monitor a continuous stream of digits (1-9) presented one at a time on-screen and press the space bar when they detect three consecutive odd or three consecutive even digits. Both accuracy and reaction time will be evaluated. - Visual Analogue Scales for Appetite — 240 minutes
This VAS questionnaire requires participants to score from 0-100 millimeters (mm) on 6 questions relating to: hunger, fullness, satiation, desire to eat, prospective consumption and satisfaction.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Remote | Minneapolis | Minnesota | Recruiting |
Other trials for the same condition
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07782229 on ClinicalTrials.gov ↗ ← All trials in the USA